Effectiveness and Safety of Liraglutide in Managing Inadequate Weight Loss and Weight Regain after Primary and Revisional Bariatric Surgery: Anthropometric and Cardiometabolic Outcomes
The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Abstract
Background No study appraised the effectiveness and safety of liraglutide in managing inadequate weight loss or weight regain (IWL/ WR) after primary versus revisional bariatric surgery (BS).Methods Retrospective study of all eligible adults who completed liraglutide 3 mg therapy for IWL/WR after primary or revisional BS at our institution between May 2016 and June 2019 (N = 145; 119 primary, 82%; 26 revisional, 18%). Changes in anthropometric and cardiometabolic parameters were assessed before the start of liraglutide and at 6 and 12 months after treatment.Results The mean age was 43.32 ± 10.49 years, and 83% were females. Patients received liraglutide at a mean of 54.10 ± 31.75 months after their BS, for WR (74.3%) or IWL (25.6%). Liraglutide significantly reduced weight and BMI among primary and revisional patients (P < 0.0001 for all) and was equally effective in these reductions for both groups. Primary patients achieved total weight loss percentage (TWL%) of 5.97% and 6.93% at 6 and 12 months. Additionally, 52.3% and 60% of the patients lost ≥ 5% of their total weight (TW) at 6 and 12 months after primary BS. Revisional patients achieved TWL% of 6.41% and 4.99% at 6 and 12 months, and 60% and 48% of patients lost ≥ 5% TW at the two time points. Liraglutide did not improve cardiometabolic outcome for primary patients; for revisional patients, only the systolic blood pressure decreased after treatment. Liraglutide was well tolerated, and the most common side effect was nausea.Conclusions Liraglutide is useful as an adjunct weight loss medication for patients achieving unsatisfactory outcomes with BS.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Fatigue was reported as an AE in 19 publications [30,43,44,54,55,63,66,67,69,70,73,81,84,85,88,[93][94][95][96].”
From Symptomatic Adverse Events and Quality of Life Related to Incretin-Based Medicines for Obesity: A Systematic Review Involving >400,000 Subjects (2025) · cites this paper as [44]
Citations
Cites
A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management
Pi-Sunyer, X., Astrup, A., Fujioka, K., Greenway, F., Halpern, A., Krempf, M., Lau, D. C. W., le Roux, C. W., Violante Ortiz, R., Jensen, C. B., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1411892 · Cited by 2,724
Astrup, A., Rössner, S., Van Gaal, L., Rissanen, A., Niskanen, L., Al Hakim, M., Madsen, J., Rasmussen, M. F., & Lean, M. E. (2009) · The Lancet · doi:10.1016/s0140-6736(09)61375-1 · Cited by 1,163
on behalf of the NN8022-1807 Investigators, Astrup, A., Carraro, R., Finer, N., Harper, A., Kunesova, M., Lean, M. E. J., Niskanen, L., Rasmussen, M. F., Rissanen, A., et al. (2012) · International Journal of Obesity · doi:10.1038/ijo.2011.158 · Cited by 757
van Can, J., Sloth, B., Jensen, C. B., Flint, A., Blaak, E. E., & Saris, W. H. M. (2014) · International Journal of Obesity · doi:10.1038/ijo.2013.162 · Cited by 537
El Ansari, W., & Elhag, W. (2021) · Obesity Surgery · doi:10.1007/s11695-020-05160-5 · Cited by 482 · cited 5×
“Yet, the options for managing IWL and WR after BS remain limited [7].”
BackgroundMethodSelf-citationWeight Regain Following Sleeve Gastrectomy—a Systematic Review
Lauti, M., Kularatna, M., Hill, A. G., & MacCormick, A. D. (2016) · Obesity Surgery · doi:10.1007/s11695-016-2152-x · Cited by 412
Influence of pouch and stoma size on weight loss after gastric bypass
Heneghan, H. M., Yimcharoen, P., Brethauer, S. A., Kroh, M., & Chand, B. (2012) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2011.09.010 · Cited by 240
Stanford, F. C., Alfaris, N., Gomez, G., Ricks, E. T., Shukla, A. P., Corey, K. E., Pratt, J. S., Pomp, A., Rubino, F., & Aronne, L. J. (2017) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2016.10.018 · Cited by 206
Definitions of Long-Term Weight Regain and Their Associations with Clinical Outcomes
Voorwinde, V., Steenhuis, I. H. M., Janssen, I. M. C., Monpellier, V. M., & van Stralen, M. M. (2020) · Obesity Surgery · doi:10.1007/s11695-019-04210-x · Cited by 174
Estimating Ideal Body Weight – A New Formula
Lemmens, H. J. M., Brodsky, J. B., & Bernstein, D. P. (2005) · Obesity Surgery · doi:10.1381/0960892054621350 · Cited by 171
Cited by
Contemporary medical, device, and surgical therapies for obesity in adults
Perdomo, C. M., Cohen, R. V., Sumithran, P., Clément, K., & Frühbeck, G. (2023) · The Lancet · doi:10.1016/s0140-6736(22)02403-5 · Cited by 738
Mok, J., Adeleke, M. O., Brown, A., Magee, C. G., Firman, C., Makahamadze, C., Jassil, F. C., Marvasti, P., Carnemolla, A., Devalia, K., et al. (2023) · JAMA Surgery · doi:10.1001/jamasurg.2023.2930 · Cited by 178
Jensen, A. B., Renström, F., Aczél, S., Folie, P., Biraima-Steinemann, M., Beuschlein, F., & Bilz, S. (2023) · Obesity Surgery · doi:10.1007/s11695-023-06484-8 · Cited by 161
Murvelashvili, N., Xie, L., Schellinger, J. N., Mathew, M. S., Marroquin, E. M., Lingvay, I., Messiah, S. E., & Almandoz, J. P. (2023) · Obesity · doi:10.1002/oby.23736 · Cited by 86
“The increased use of MBS for treating severe obesity and adiposity-related comorbidities has been supported by recent studies that have shown benefits in T2DM [6], nonalcoholic fatty liver disease [7], and cardiovascular outcomes [8], as well as cancer occurrence [9] and mortality [10].”
Dutta, D., Nagendra, L., Joshi, A. S., Krishnasamy, S., Sharma, M., & Parajuli, N. (2024) · Obesity Surgery · doi:10.1007/s11695-024-07175-8 · Cited by 67
Metadata
- Authors
- Elhag, W., & El Ansari, W.
- Affiliations
- Hamad General Hospital (QA)
- Venue
- Obesity Surgery
- Published
- 2022-01-20
- Volume
- 32
- Issue
- 4
- Pages
- 1005-1015
- ISSN
- 0960-8923 (ISSN-L)
- 1708-0428
- OpenAlex
- W4205898905
- Cited by
- 49
- References
- 41
- Citations by year
- 2026: 8 · 2025: 14 · 2024: 17 · 2023: 10
- FWCI
- 9.84
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Obesity Surgery (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Surgery › Bariatric Surgery and Outcomes
- Health Sciences › Medicine › Pharmacology (medical) › Pharmacology and Obesity Treatment
- Health Sciences › Medicine › Surgery › Body Contouring and Surgery
- Keywords
- liraglutide
- MeSH terms
- Liraglutide, Adult, Cardiovascular Diseases, Female, Humans, Male, Middle Aged, Obesity, Morbid, Laparoscopy, Reoperation, Retrospective Studies, Gastric Bypass, Weight Gain, Weight Loss, Treatment Outcome, Bariatric Surgery
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Effectiveness and Safety of Liraglutide in Managing Inadequate Weight Loss and Weight Regain after Primary and Revisional Bariatric Surgery: Anthropometric and Cardiometabolic Outcomes. https://app.cochat.ai/papers/10.1007/s11695-021-05884-y
- The paper
- Elhag, W., & El Ansari, W. (2022). Effectiveness and Safety of Liraglutide in Managing Inadequate Weight Loss and Weight Regain after Primary and Revisional Bariatric Surgery: Anthropometric and Cardiometabolic Outcomes. Obesity Surgery. https://doi.org/10.1007/s11695-021-05884-y
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.